Mr. Terence Young

Chair of Drug Safety Canada; Former MP for Oakville 2008-2015

Summer School Presentation: Clinical trial data transparency in Vanessa’s Law: Is five years of delay, pretence and outright opposition from Health Canada regulatory capture, or old-fashioned political interference? 

 

From 2008 to 2015, Terence Young served in the House of Commons as the Member of Parliament for Oakville. Prior to entering federal politics, from 1995 to 1999, Terence served as MPP for north Oakville in the Ontario Legislative Assembly. Terence founded Drug Safety Canada in 2001, a non-profit group dedicated to increasing prescription drug safety, after his 15-year-old daughter Vanessa died of a heart arrhythmia caused by the Johnson & Johnson prescription drug Prepulsid 

 

During his time in the House of Commons, Terence earned the reputation as one of the most productive MPs on Parliament Hill and considers the unanimous passage of Bill C-17 – also known as Vanessa’s Law: The Protecting Canadians from Unsafe Drugs Act – as his major achievement. Vanessa’s Law has been called the most significant update to The Food and Drugs Act in 50 years, and empowers the Minister of Health to order label changes for risky drugs, new safety studies, and unsafe drugs off the market. It also makes compulsory the reporting of all serious adverse drug reactions in hospitals and the release of clinical trial data to researchers by Health Canada.        

 

Terence lives in Oakville with Gloria, his wife of 39 years, and is proud father to two adult children: Madeline, and Hart, and one granddaughter Eleanor.